List of insiders holdings for GILEAD SCIENCES INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
MARTIN JOHN C Director | 2019-02-08 17:52:24 | 2,887,225 0 | 2,887,225 | Form 4 |
BISCHOFBERGER NORBERT W EVP, R&D and CSO | 2018-02-23 18:58:48 | 19,602 2,317,800 | 2,337,402 | Form 4 |
MILLIGAN JOHN F President and CEO | 2018-11-29 20:42:18 | 1,574,306 0 | 1,574,306 | Form 4 |
MOORE GORDON EARLE Director | 2012-08-16 16:32:59 | 0 1,063,839 | 1,063,839 | Form 4 |
DAVIGNON ETIENNE Director | 2016-05-10 16:26:43 | 838,652 0 | 838,652 | Form 4 |
O'Day Daniel Patrick Chairman & CEO | 2024-12-11 19:13:55 | 606,505 0 | 606,505 | Form 4 |
DENNY JAMES M Director | 2013-01-09 16:57:03 | 210,060 97,998 | 308,058 | Form 5 |
PERRY MARK L EVP Operations | 2004-02-04 18:32:57 | 273,292 5,600 | 278,892 | Form 4 |
Washington Robin L EVP, CFO | 2019-03-14 16:48:02 | 33,538 129,241 | 162,779 | Form 4 |
Meyers James R EVP Worldwide Commercial Ops | 2018-02-23 18:41:02 | 5,393 132,083 | 137,476 | Form 4 |
Dickinson Andrew D Chief Financial Officer | 2024-12-17 17:27:49 | 132,373 0 | 132,373 | Form 4 |
WILSON GAYLE E Director | 2020-05-07 19:17:13 | 129,052 0 | 129,052 | Form 4 |
McHutchison John G Chief Scientific Off/HeadR&D | 2019-02-08 19:55:35 | 121,153 0 | 121,153 | Form 4 |
Parsey Merdad Chief Medical Officer | 2024-12-11 19:24:27 | 119,603 0 | 119,603 | Form 4 |
HULL CORDELL W Director | 2003-11-06 12:50:08 | 112,000 0 | 112,000 | Form 4 |
Mercier Johanna Chief Commercial Officer | 2024-12-11 19:08:25 | 111,333 0 | 111,333 | Form 4 |
WOLD OLSEN PER Director | 2021-05-07 19:02:38 | 102,060 0 | 102,060 | Form 4 |
Carter Paul Rutherford EVP Commercial Ops | 2016-08-03 16:48:37 | 93,151 0 | 93,151 | Form 4 |
Alton Gregg H Chief Patient Officer | 2019-03-05 19:48:39 | 83,216 0 | 83,216 | Form 4 |
Patterson Sandra SVP, Controllership | 2024-12-16 16:22:28 | 72,990 0 | 72,990 | Form 4 |
Metza Kristen SVP, Human Resources | 2012-11-05 20:26:55 | 61,005 0 | 61,005 | Form 4 |
INOUYE MICHAEL K SVP | 2004-01-30 17:17:12 | 57,710 0 | 57,710 | Form 4 |
SHULTZ GEORGE P Director | 2005-08-10 18:16:45 | 0 55,000 | 55,000 | Form 4 |
Cogan John Francis Director | 2020-05-05 16:28:36 | 54,860 0 | 54,860 | Form 4 |
Pletcher Brett A EVP,Corp Affairs & Gen Counsel | 2022-06-13 20:01:37 | 49,945 0 | 49,945 | Form 4 |
Telman Deborah H EVP, Corporate Affairs & GC | 2024-12-11 19:51:40 | 49,706 0 | 49,706 | Form 4 |
Wilfong Diane E. SVP, Controller & CAO | 2023-02-07 17:47:01 | 43,070 0 | 43,070 | Form 4 |
HILLS CARLA A Director | 2016-05-10 16:39:34 | 39,285 0 | 39,285 | Form 4 |
BARTON JACQUELINE K Director | 2024-05-09 17:57:24 | 37,188 0 | 37,188 | Form 4 |
Whitley Richard James Director | 2021-05-07 18:53:13 | 37,086 0 | 37,086 | Form 4 |
BERG PAUL Director | 2011-05-13 20:36:56 | 36,864 0 | 36,864 | Form 4 |
Kramer Kelly A. Director | 2024-05-09 15:38:08 | 30,242 0 | 30,242 | Form 4 |
MOORE NICHOLAS G Director | 2018-04-02 19:38:51 | 27,376 0 | 27,376 | Form 4 |
YOUNG KEVIN Chief Operating Officer | 2018-02-23 18:49:56 | 25,612 0 | 25,612 | Form 4 |
MANWANI HARISH Director | 2024-05-09 17:16:26 | 25,521 0 | 25,521 | Form 4 |
Rodriguez Javier Director | 2024-05-09 17:26:52 | 23,350 0 | 23,350 | Form 4 |
WELTERS ANTHONY Director | 2024-05-09 17:23:01 | 22,880 0 | 22,880 | Form 4 |
Bluestone Jeffrey Director | 2024-11-27 18:14:41 | 20,650 0 | 20,650 | Form 4 |
Horning Sandra Director | 2024-05-09 15:46:28 | 20,449 0 | 20,449 | Form 4 |
MADIGAN JOHN W Director | 2017-05-11 18:45:47 | 18,548 0 | 18,548 | Form 4 |
LOVE TED W Director | 2024-05-09 17:30:52 | 15,470 0 | 15,470 | Form 4 |
Hamill Laura EVP, Worldwide Commercial Ops | 2019-05-10 18:55:09 | 6,340 0 | 6,340 | Form 4 |
Lofton Kevin E Director | 2024-03-29 17:19:56 | 3,258 0 | 3,258 | Form 4 |
Montgomery Alan Bruce SVP, Respiratory Therapeutics | 2007-05-15 14:23:37 | 0 0 | 0 | Form 4 |
YANG TAIYIN SVP, Pharm Dev & Mfg | 2007-05-15 14:22:07 | 0 0 | 0 | Form 4 |
LEE WILLIAM A SVP, Research | 2007-05-15 14:22:52 | 0 0 | 0 | Form 4 |
CARACCIOLO ANTHONY SVP, Manufacturing | 2007-05-15 14:23:55 | 0 0 | 0 | Form 4 |
TOOLE JOHN J SVP, Clinical Research | 2007-05-15 14:22:27 | 0 0 | 0 | Form 4 |
DORSA CAROLINE SVP, Chief Financial Officer | 2008-01-29 17:38:33 | 0 0 | 0 | Form 4 |
LANGE LOUIS G Former EVP Cardio Therapeutics | 2009-06-05 17:38:32 | 0 0 | 0 | Form 4 |